Beyond LDL-C: Optimizing ASCVD Risk Reduction in Diabetes Care empowers endocrinologists and frontline clinicians to tackle the substantial residual cardiovascular risk that persists in adults with type 2 diabetes despite optimal glycemic control. You’ll explore how diabetes drives long-term LDL-C exposure and ASCVD progression, learn to implement proactive risk stratification and post-event LDL-C screening, and master guideline-recommended targets through personalized lipid-lowering strategies. By addressing key comorbidities—hypercholesterolemia, hypertension, obesity, and dyslipidemia—this course ensures you can close care gaps that leave many patients vulnerable to CV events.
Through case-based scenarios you will refine your ability to identify high-risk patients, tailor interventions, and engage in shared decision-making that boosts adherence and outcomes. Register today to transform your clinical practice, reduce preventable CV events, and deliver the comprehensive cardiovascular protection every patient with diabetes deserves.
July 31, 2026
July 31, 2027
Upon completion of the educational activity, participants should be better able to:
- Apply current AACE guidelines to intensify statin and non-statin therapy in patients with T2D not at LDL-C goal.
- Determine treatment strategies that prioritize early and sustained LDL-C lowering in patients with T2D.
- Compare current lipid management guideline recommendations to optimize therapy for patients with T2D.
- Adapt shared decision-making strategies when discussing lipid-lowering therapies with patients with T2D.
- Choose practical strategies to streamline patient access to lipid-lowering therapies.
This program is intended for endocrinologists and frontline clinicians managing ASCVD risk in patients with diabetes, including cardiologists, pharmacists, PCPs, and advanced practice professionals (such as nurse practitioners [NPs], physician assistants [PAs], etc.).
SPEAKERS
FACULTY
Jeff Unger, MD, FAAFP, FACE, DACD
Director, Unger Primary Care Concierge Medical Group
Rancho Cucamonga, CA
Associate Medical Director Mission Hospice
Assistant Clinical Professor of Family Medicine
UC Riverside School of Medicine
Javier Morales, MD, FACP, FACE
Vice President & Principal Clinical Trials Investigator
Advanced Internal Medicine Group
Associate Clinical Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Hofstra University
Abhishek Shrivastava, MD MMsc DMsc PGD FACE
Endocrinologist
R&R Hormone Clinic
India
This activity is supported by an independent medical education grant from Merck.